Browsing Bergen Open Research Archive by Author "Nilsen, Elisabeth Berge"

Now showing items 1-3 of 3

    • The ESSO core curriculum committee update on surgical oncology 

      van der Hage, Jos; Sandrucci, Sergio; Audisio, Riccardo; Wyld, Lynda; Søreide, Kjetil; Amaral, Teresa; Bahadoer, Viren; Beets, Geerard; Benstead, Kim; Nilsen, Elisabeth Berge; Bol, Kalijn; Brandl, Andreas; Braun, Jerry; Cufer, Tanja; Dopazo, Cristina; Edhemovic, Ibrahim; Eriksen, Jesper Grau; Fiore, Marco; van Ginhoven, Tessa; Gonzalez-Moreno, Santiago; Hutteman, Merlijn; Masannat, Yazan; Onesti, Elisa Concetta; Rau, Beate; De Reijke, Theo; Rubio, Isabel T.; Ruurda, Jelle; Soreide, Kjetil; Stättner, Stefan; Trapani, Dario; D'Ugo, Domenico; Vriens, Menno; Eriksson, Ane Gerda Zahl (Journal article; Peer reviewed, 2021)
      Introduction Surgical oncology is a defined specialty within the European Board of Surgery within the European Union of Medical Specialists (UEMS). Variation in training and specialization still occurs across Europe. There ...

    • Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins 

      Torkildsen, Cecilie Fredvik; Austdal, Marie; Iversen, Ann-Charlotte; Bathen, Tone Frost; Giskeødegård, Guro F.; Nilsen, Elisabeth Berge; Iversen, Grete Alræk; Sande, Ragnar; Bjørge, Line; Thomsen, Liv Cecilie Vestrheim (Journal article; Peer reviewed, 2023)
      High-grade serous ovarian carcinoma (HGSOC) is the most common and deadliest ovarian cancer subtype. Despite advances in treatment, the overall prognosis remains poor. Regardless of efforts to develop biomarkers to predict ...

    • Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer 

      Elgaaen, Bente Vilming; Dahl, Jørgen Fallås; Bentzen, Anne Gry; Ingebrigtsen, Vibeke Anett; Nilsen, Elisabeth Berge; Vistad, Ingvild; Dørum, Anne; Popova, Olesya; Bjørge, Line; Zucknick, Manuela; Aune, Guro; Lindemann, Kristina Yvonne Kathe (Journal article; Peer reviewed, 2023)
      Objectives The aim of this study was to provide real-world efficacy and safety data on niraparib maintenance treatment in patients with non-germline (gBRCA)1/2 mutated platinum-sensitive recurrent ovarian cancer. Methods ...